Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.07%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +36.76%
#5 Humanity Humanity +25.32%
#6 Enso Enso +23.07%
#7 Walrus Walrus +22.73%
#8 Tutorial Tutorial +19.23%
#9 Codatta Codatta +16.99%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR
Clasificación en acciones #36561
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Precio por acción
$1.73
Última sincronización: 2025-06-17
Capitalización bursátil
$2.55M
Cambio (1 día)
-0.29%
Cambio (1 año)
0.00%
País
US
Comercio Eiger BioPharmaceuticals, Inc. (EIGR)

Categoría

Healthcare
Precio EIGR con Capital del mercado a B
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
EIGR
$1.73
Capitalización de mercado de Eiger BioPharmaceuticals, Inc.(EIGR)
Capitalización bursátil: $2.55M
A fecha de August 2026, Eiger BioPharmaceuticals, Inc. tiene una capitalización de mercado de $2.55M. Esto convierte a Eiger BioPharmaceuticals, Inc. en la 36561st empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Eiger BioPharmaceuticals, Inc. desde 2014 hasta 2026
EIGR en comparación con los más populares 5 títulos stocks
Precio por EIGR Activo B Capital del mercado en B Resultados
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$3,684,828 $2.55M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +213,613,124.72%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$3,034,731 $2.55M
Apple Inc. Apple Inc.
AAPL
$4.490T +175,926,341.05%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$2,813,303 $2.55M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +163,089,914.17%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$2,484,780 $2.55M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +144,045,097.36%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$1,914,807 $2.55M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +111,003,211.28%